Promoted Content Promoted Content


Find Clinical Drug Development Pipelines & Deals | PipelineProspector


All Data

Filters Filter
filter News Type
    filter Company
      filter Product Type
        filter Deal Size
          filter Upfront Payment

            Active Filter(s):

            Product Type


            Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

            Lead Product(s): Lurbinectedin

            Therapeutic Area: Oncology Product Name: Zepzelca

            Highest Development Status: Undisclosed Product Type: Small molecule

            Partner/Sponsor/Collaborator: Stand Up To Cancer

            Deal Size: Undisclosed Upfront Cash: Undisclosed

            Deal Type: Collaboration August 10, 2021


            The collaboration will provide SU2C-funded researchers access to two Jazz molecules and funds to support one or more research projects over three years. One of the projects would help explore clinical use of lurbinectedin in rare and hard to treat pediatric solid tumors.